{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T23:12:38Z","timestamp":1718320358617},"reference-count":24,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.9503","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T06:40:12Z","timestamp":1537944012000},"source":"Crossref","is-referenced-by-count":2,"title":["Methylation level of Rap1GAP and the clinical significance in MDS"],"prefix":"10.3892","author":[{"given":"Wen\u2011Jing","family":"Ding","sequence":"first","affiliation":[{"name":"Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, Jiangsu 215006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, Jiangsu 215006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi\u2011Xing","family":"Chen","sequence":"additional","affiliation":[{"name":"Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, Jiangsu 215006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan\u2011Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, Jiangsu 215006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan\u2011Li","family":"Dong","sequence":"additional","affiliation":[{"name":"Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, Jiangsu 215006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian\u2011Nong","family":"Cen","sequence":"additional","affiliation":[{"name":"Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, Jiangsu 215006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao\u2011Fei","family":"Qi","sequence":"additional","affiliation":[{"name":"Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, Jiangsu 215006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, Jiangsu 215006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su\u2011Ning","family":"Chen","sequence":"additional","affiliation":[{"name":"Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, Jiangsu 215006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"key20200714084723_b1-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1182\/blood-2008-06-163246","article-title":"Aberrant DNA methylation is a dominant mechanism in MDS progression to AML","volume":"113","author":"Jiang","year":"2009","journal-title":"Blood"},{"key":"key20200714084723_b2-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1182\/blood-2013-02-451757","article-title":"The myelodysplastic syndrome as a prototypical epigenetic disease","volume":"121","author":"Issa","year":"2013","journal-title":"Blood"},{"key":"key20200714084723_b3-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1182\/blood-2013-06-460295","article-title":"The biology and clinical impact of genetic lesions in myeloid malignancies","volume":"122","author":"Lindsley","year":"2013","journal-title":"Blood"},{"key":"key20200714084723_b4-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc1571","article-title":"Detection and interpretation of altered methylation patterns in cancer cells","volume":"5","author":"Ushijima","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key20200714084723_b5-ol-0-0-9503","first-page":"612","article-title":"Protein RAP1GAP in human myelodysplastic syndrome detected by flow cytometry and its clinical relevance","volume":"17","author":"Ika","year":"2009","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"key20200714084723_b6-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4238\/vol7-2gmr395","article-title":"Expression of Rap1GAP in human myeloid disease following microarray selection","volume":"7","author":"Qi","year":"2008","journal-title":"Genet Mol Res"},{"key":"key20200714084723_b7-ol-0-0-9503","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"key20200714084723_b8-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3892\/ol.2013.1312","article-title":"DNA methylation state of the galectin-3 gene represents a potential new marker of thyroid malignancy","volume":"6","author":"Keller","year":"2013","journal-title":"Oncol Lett"},{"key":"key20200714084723_b9-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1200\/JCO.2010.30.9245","article-title":"Low-dose decitabine versus best supportive care in elderly patients with intermediate-or high-risk Myelodysplastic Syndrome (MDS) ineligible for intensive chemotherapy: Final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group","volume":"29","author":"L\u00fcbbert","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20200714084723_b10-ol-0-0-9503","first-page":"1513","article-title":"Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: Problems and approaches","volume":"91","author":"Deschler","year":"2006","journal-title":"Haematologica"},{"key":"key20200714084723_b11-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.leukres.2009.12.017","article-title":"From FAB to 2008 WHO classification: The wide heterogeneity of refractory anemia subtype among different countries","volume":"34","author":"Breccia","year":"2010","journal-title":"Leuk Res"},{"key":"key20200714084723_b12-ol-0-0-9503","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.V96.6.2012","article-title":"Isolation and characterization of hematopoietic progenitor\/stem cells in 5q-deleted myelodysplastic syndromes: Evidence for involvement at the hematopoietic stem cell level","volume":"96","author":"Nilsson","year":"2000","journal-title":"Blood"},{"key":"key20200714084723_b13-ol-0-0-9503","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"key20200714084723_b14-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1038\/sj.leu.2403489","article-title":"The international prognostic scoring system (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)","volume":"18","author":"Hasle","year":"2004","journal-title":"Leukemia"},{"key":"key20200714084723_b15-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1182\/blood-2005-03-1062","article-title":"Multiple roles of Rap1 in hematopoietic cells: Complementary versus antagonistic functions","volume":"106","author":"Stork","year":"2005","journal-title":"Blood"},{"key":"key20200714084723_b16-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/0008-5472.CAN-05-3025","article-title":"Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer","volume":"66","author":"Zhang","year":"2006","journal-title":"Canc Res"},{"key":"key20200714084723_b17-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"24636","DOI":"10.1074\/jbc.M113.464594","article-title":"Tumor cell migration and invasion are enhanced by depletion of Rap1 GTPase-activating protein (Rap1GAP)","volume":"288","author":"Tsygankova","year":"2013","journal-title":"J Biol Chem"},{"key":"key20200714084723_b18-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/0008-5472.CAN-09-2812","article-title":"Downregulation of Rap1GAP through epigenetic silencing and loss of heterozygosity promotes invasion and progression of thyroid tumors","volume":"70","author":"Zuo","year":"2010","journal-title":"Cancer Res"},{"key":"key20200714084723_b19-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1158\/0008-5472.CAN-08-2399","article-title":"Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration","volume":"69","author":"Zheng","year":"2009","journal-title":"Cancer Res"},{"key":"key20200714084723_b20-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3324\/haematol.2012.073080","article-title":"The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation","volume":"98","author":"Maffei","year":"2013","journal-title":"Haematologica"},{"key":"key20200714084723_b21-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1172\/JCI67846","article-title":"Podocyte-specific Rap1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury","volume":"124","author":"Potla","year":"2014","journal-title":"J Clin Invest"},{"key":"key20200714084723_b22-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3892\/or.2012.1825","article-title":"Rap1GAP alters leukemia cell differentiation, apoptosis and invasion in vitro","volume":"28","author":"Qiu","year":"2012","journal-title":"Oncol Rep"},{"key":"key20200714084723_b23-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canlet.2012.01.022","article-title":"Rap1GAP regulates renal cell carcinoma invasion","volume":"320","author":"Kim","year":"2012","journal-title":"Cancer Lett"},{"key":"key20200714084723_b24-ol-0-0-9503","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.exphem.2012.10.006","article-title":"Effects of DNA methyltransferase inhibitors (DNMTIs) on MDS-derived cell lines","volume":"41","author":"Tsujioka","year":"2013","journal-title":"Exp Hematol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:44:14Z","timestamp":1594719854000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.9503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":24,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.9503","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]}}}